Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells

Stem Cells and Development

Volumn 17, Issue 5, 2008, Pages 869-881

  Westfall, Suzanne D ^a,b   Sachdev, Shrikesh ^b   Das, Padmalaya ^a,c   Hearne, Leonard B ^a   Hannink, Mark ^b   Roberts, R Michael ^a,b   Ezashi, Toshihiko ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LEFTY2; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OXYGEN;

ARTICLE; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL MATURATION; CELL RENEWAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; CELL LINE; CYTOLOGY; DEVELOPMENTAL GENE; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GLYCOLYSIS; METABOLISM; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PLURIPOTENT STEM CELL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE; DOWN-REGULATION; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, DEVELOPMENTAL; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXIDATIVE STRESS; OXYGEN; PENTOSE PHOSPHATE PATHWAY; PLURIPOTENT STEM CELLS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 58149154747     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0240     Document Type: Article

References (79)

1. Odorico JS, DS Kaufman and JA Thomson. (2001). Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193-204.
2. Stojkovic M, M Lako, T Strachan and A Murdoch. (2004). Derivation, growth and applications of human embryonic stem cells. Reproduction 128:259-267.
3. Menendez P, C Bueno and L Wang. (2006). Human embryonic stem cells: a journey beyond cell replacement therapies. Cytotherapy 8:530-541.
4. Jones JM and JA Thomson. (2000). Human embryonic stem cell technology. Semin Reprod Med 18:219-223.
5. Amit M and J Itskovitz-Eldor. (2002). Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200:225-232.
6. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
7. Fischer B and BD Bavister. (1993). Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil 99:673-679.
8. Ottosen LD, J Hindkaer, M Husth, DE Petersen, J Kirk and HJ Ingerslev. (2006). Observations on intrauterine oxygen tension measured by fibre-optic microsensors. Reprod Biomed Online 13:380-385.
9. Ezashi T, P Das and RM Roberts. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 102:4783-4788.
10. Wenger RH and M Gassmann. (1997). Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378:609-616.
11. Greijer AE, P van der Groep, D Kemming, A Shvarts, GL Semenza, GA Meijer, MA van de Wiel, JA Belien, PJ van Diest and E van der Wall. (2005). Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206:291-304.
12. Semenza GL, PH Roth, HM Fang and GL Wang. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763.
13. Harvey AJ, KL Kind, M Pantaleon, DT Armstrong and JG Thompson. (2004). Oxygen-regulated gene expression in bovine blastocysts. Biol Reprod 71:1108-1119.
14. Iyer NV, LE Kotch, F Agani, SW Leung, E Laughner, RH Wenger, M Gassmann, JD Gearhart, AM Lawler, AY Yu and GL Semenza. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
15. Keith B and MC Simon. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465-472.
16. Giles JR and RH Foote. (1997). Effects of gas atmosphere, platelet-derived growth factor and leukemia inhibitory factor on cell numbers of rabbit embryos cultured in a protein-free medium. Reprod Nutr Dev 37:97-104.
17. Petersen A, AL Mikkelsen and S Lindenberg. (2005). The impact of oxygen tension on developmental competence of post-thaw human embryos. Acta Obstet Gynecol Scand 84:1181-1184.
18. Thompson JG, AC Simpson, PA Pugh, PE Donnelly and HR Tervit. (1990). Effect of oxygen concentration on in-vitro development of preimplantation sheep and cattle embryos. J Reprod Fertil 89:573-578.
19. Booth PJ, P Holm and H Callesen. (2005). The effect of oxygen tension on porcine embryonic development is dependent on embryo type. Theriogenology 63:2040-2052.
20. Rinaudo PF, G Giritharan, S Talbi, AT Dobson and RM Schultz. (2006). Effects of oxygen tension on gene expression in preimplantation mouse embryos. Fertil Steril 86 Suppl 4:1252-1265, e1251-1236.
21. Covello KL, J Kehler, H Yu, JD Gordan, AM Arsham, CJ Hu, PA Labosky, MC Simon and B Keith. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20:557-570.
22. Hu CJ, S Iyer, A Sataur, KL Covello, LA Chodosh and MC Simon. (2006). Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol 26:3514-3526.
23. Pan GJ, ZY Chang, HR Scholer and D Pei. (2002). Stem cell pluripotency and transcription factor Oct4. Cell Res 12:321-329.
24. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974.
25. Harbig J, R Sprinkle and SA Enkemann. (2005). A sequence-based identification of the genes detected by probesets on the Affymetrix U133 plus 2.0 array. Nucleic Acids Res 33:e31.
26. Bhattacharya B, J Cai, Y Luo, T Miura, J Mejido, SN Brimble, X Zeng, TC Schulz, MS Rao and RK Puri. (2005). Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol 5:22.
27. Cai J, J Chen, Y Liu, T Miura, Y Luo, JF Loring, WJ Freed, MS Rao and X Zeng. (2006). Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells 24:516-530.
28. Kim CG, JJ Lee, DY Jung, J Jeon, HS Heo, HC Kang, JH Shin, YS Cho, KJ Cha, CG Kim, BR Do, KS Kim and HS Kim. (2006). Profiling of differentially expressed genes in human stem cells by cDNA microarray. Mol Cells 21:343-355.
29. Rao RR, JD Calhoun, X Qin, R Rekaya, JK Clark and SL Stice. (2004). Comparative transcriptional profiling of two human embryonic stem cell lines. Biotechnol Bioeng 88:273-286.
30. Rao RR and SL Stice. (2004). Gene expression profiling of embryonic stem cells leads to greater understanding of pluripotency and early developmental events. Biol Reprod 71:1772-1778.
31. Zeng X, T Miura, Y Luo, B Bhattacharya, B Condie, J Chen, I Ginis, I Lyons, J Mejido, RK Puri, MS Rao and WJ Freed. (2004). Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22:292-312.
32. Brimble SN, X Zeng, DA Weiler, Y Luo, Y Liu, IG Lyons, WJ Freed, AJ Robins, MS Rao and TC Schulz. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13:585-597.
33. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
34. Loh YH, Q Wu, JL Chew, VB Vega, W Zhang, X Chen, G Bourque, J George, B Leong, J Liu, KY Wong, KW Sung, CW Lee, XD Zhao, KP Chiu, L Lipovich, VA Kuznetsov, P Robson, LW Stanton, CL Wei, Y Ruan, B Lim and HH Ng. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38:431-440.
35. Wang J, S Rao, J Chu, X Shen, DN Levasseur, TW Theunissen and SH Orkin. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature 444:364-368.
36. Nichols J, B Zevnik, K Anastassiadis, H Niwa, D Klewe-Nebenius, I Chambers, H Scholer and A Smith. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
37. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, M Maruyama, M Maeda and S Yamanaka. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642.
38. Richards M, SP Tan, JH Tan, WK Chan and A Bongso. (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22:51-64.
39. Avilion AA, SK Nicolis, LH Pevny, L Perez, N Vivian and R Lovell-Badge. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17:126-140.
40. Ben-Shushan E, JR Thompson, LJ Gudas and Y Bergman. (1998). Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 18:1866-1878.
41. Armstrong L, G Saretzki, H Peters, I Wappler, J Evans, N Hole, T von Zglinicki and M Lako. (2005). Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23:516-529.
42. Boyer LA, D Mathur and R Jaenisch. (2006). Molecular control of pluripotency. Curr Opin Genet Dev 16:455-462.
43. Babaie Y, R Herwig, B Greber, TC Brink, W Wruck, D Groth, H Lehrach, T Burdon and J Adjaye. (2007). Analysis of OCT4 dependent transcriptional networks regulating self renewal and pluripotency in human embryonic stem cells. Stem Cells 25:500-510.
44. Besser D. (2004). Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279:45076-45084.
45. James D, AJ Levine, D Besser and A Hemmati-Brivanlou. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282.
46. Vallier L, M Alexander and RA Pedersen. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118:4495-4509.
47. Kutz SM, CE Higgins, R Samarakoon, SP Higgins, RR Allen, L Qi and PJ Higgins. (2006). TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 312:1093-1105.
48. Buck A, M Buchholz, M Wagner, G Adler, T Gress and V Ellenrieder. (2006). The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer. Mol Cancer Res 4:861-872.
49. Calhoun JD, RR Rao, S Warrenfeltz, R Rekaya, S Dalton, J McDonald and SL Stice. (2004). Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem Biophys Res Commun 323:453-464.
50. Dvash T, Y Mayshar, H Darr, M McElhaney, D Barker, O Yanuka, KJ Kotkow, LL Rubin, N Benvenisty and R Eiges. (2004). Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod 19:2875-2883.
51. Aghajanova L, H Skottman, AM Stromberg, J Inzunza, R Lahesmaa and O Hovatta. (2006). Expression of leukemia inhibitory factor and its receptors is increased during differentiation of human embryonic stem cells. Fertil Steril 86 Suppl 4:1193-1209.
52. Mathers J, JA Fraser, M McMahon, RD Saunders, JD Hayes and LI McLellan. (2004). Antioxidant and cytoprotective responses to redox stress. Biochem Soc Symp:157-176.
53. Chen XL and C Kunsch. (2004). Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10:879-891.
54. Kobayashi M and M Yamamoto. (2005). Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7:385-394.
55. Wu Y, J Wu, DY Lee, A Yee, L Cao, Y Zhang, C Kiani and BB Yang. (2005). Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol 24:3-13.
56. Winchester BG. (2001). Lysosomal membrane proteins. Eur J Paediatr Neurol 5 Suppl A:11-19.
57. Levtchenko E, A de Graaf-Hess, M Wilmer, L van den Heuvel, L Monnens and H Blom. (2005). Altered status of glutathione and its metabolites in cystinotic cells. Nephrol Dial Transplant 20:1828-1832.
58. Manalo DJ, A Rowan, T Lavoie, L Natarajan, BD Kelly, SQ Ye, JG Garcia and GL Semenza. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105:659-669.
59. Bruick RK. (2000). Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 97:9082-9087.
60. Kothari S, J Cizeau, E McMillan-Ward, SJ Israels, M Bailes, K Ens, LA Kirshenbaum and SB Gibson. (2003). BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22:4734-4744.
61. Shoshani T, A Faerman, I Mett, E Zelin, T Tenne, S Gorodin, Y Moshel, S Elbaz, A Budanov, A Chajut, H Kalinski, I Kamer, A Rozen, O Mor, E Keshet, D Leshkowitz, P Einat, R Skaliter and E Feinstein. (2002). Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283-2293.
62. Graven KK, RF Troxler, H Kornfeld, MV Panchenko and HW Farber. (1994). Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 269:24446-24453.
63. Forsyth NR, A Musio, P Vezzoni, AH Simpson, BS Noble and J McWhir. (2006). Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 8:16-23.
64. Fehrer C, R Brunauer, G Laschober, H Unterluggauer, S Reitinger, F Kloss, C Gully, R Gassner and G Lepperdinger. (2007). Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745-757.
65. D'Ippolito G, S Diabira, GA Howard, BA Roos and PC Schiller. (2006). Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39:513-522.
66. Wang F, S Thirumangalathu and MR Loeken. (2006). Establishment of new mouse embryonic stem cell lines is improved by physiological glucose and oxygen. Cloning Stem Cells 8:108-116.
67. Niwa H, J Miyazaki and AG Smith. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376.
68. Shimozaki K, K Nakashima, H Niwa and T Taga. (2003). Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. Development 130:2505-2512.
69. Hay DC, L Sutherland, J Clark and T Burdon. (2004). Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22:225-235.
70. Schier AF and MM Shen. (2000). Nodal signalling in vertebrate development. Nature 403:385-389.
71. Sakuma R, Y Ohnishi Yi, C Meno, H Fujii, H Juan, J Takeuchi, T Ogura, E Li, K Miyazono and H Hamada. (2002). Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 7:401-412.
72. Schier AF. (2003). Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 19:589-621.
73. Hu CJ, LY Wang, LA Chodosh, B Keith and MC Simon. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374.
74. Semenza GL. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
75. Sowter HM, RR Raval, JW Moore, PJ Ratcliffe and AL Harris. (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63:6130-6134.
76. Wang V, DA Davis, M Haque, LE Huang and R Yarchoan. (2005). Differential gene up-regulation by hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in HEK293T Cells. Cancer Res 65:3299-3306.
77. Holmquist-Mengelbier L, E Fredlund, T Lofstedt, R Noguera, S Navarro, H Nilsson, A Pietras, J Vallon-Christersson, A Borg, K Gradin, L Poellinger and S Pahlman. (2006). Recruitment of HIF-1[alpha] and HIF-2[alpha] to common target genes is differentially regulated in neuroblastoma: HIF-2[alpha] promotes an aggressive phenotype. Cancer Cell 10:413-423.
78. Keith B and MC Simon. (2007). Hypoxia-Inducible Factors, Stem Cells, and Cancer. Cell 129:465-472.
79. Sato M, T Tanaka, K Maemura, T Uchiyama, H Sato, T Maeno, T Suga, T Iso, Y Ohyama, M Arai, J Tamura, H Sakamoto, R Nagai and M Kurabayashi. (2004). The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells. Am J Respir Cell Mol Biol 31:209-215.